Interleukin-12 decorated nanosized semiflexible Immunofilaments enable directed targeting and augmented IFNγ responses of natural killer cells
Acta Biomaterialia · 2025
DOI: 10.1016/j.actbio.2024.11.012 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Biomaterialia, 2025. Verfasst von Lea Weiss und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical BioSciences, Radboudumc, Geert Grooteplein 26, Nijmegen, GA 6525, the Netherlands; Institute for Chemical Immunology, Nijmegen,…. Hauptthemen laut MEDLINE: Killer Cells, Natural, Interleukin-12, Interferon-gamma. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Immunotherapies are a powerful strategy to treat cancer by modulating the immune system to raise an anti-tumor immune response. A prime example of immunotherapies are cytokines - small immunomodulatory molecules that are widely used to stimulate immune cells. Undirected administration of cytokines, however, can cause severe side effects, preventing the use of potent cytokines, such as Interleukin (IL)-12, which induces IFNγ responses by cytotoxic effector lymphocytes, including NK cells. Biomaterials, like nanoparticles, can encapsulate IL-12 and accumulate at the tumor site to alleviate side effects. Yet, the released IL-12 might not be directly targeted to extracellular IL-12 receptors on the specific effector cells, thereby potentially compromising the cytokine's therapeutic efficacy. Here, we develop a polymer-based platform to target NK cells, which we call immunofilaments. Immunofilaments are nanosized linear polymers that present an anti-CD16 antibody and IL-12 effectively to NK cells and lead to synergistic NK cell activation as highlighted by an increase in TNFα and IFNγ production and upregulation of multiple activation markers, including CD25, CD69, and degranulation marker CD107a. NK cell proliferation is enhanced in the presence of both anti-CD16 antibody and IL-12 compared to giving IL-12 separately. Finally, we demonstrate that the IF platform is suitable for in vivo applications, as immunofilaments readily activate human NK cells upon administration to mice. STATEMENT OF SIGNIFICANCE: IL-12 is a potent cytokine that stimulates IFNγ responses in NK cells, which supports an anti-tumor immune response. Due to its high potency, the delivery of IL-12 needs to be highly controlled to prevent severe adverse side effects, which can be achieved by using biomaterials. This study shows that nanosized polymers termed Immunofilaments can be used to immobilize IL-12 and effectively target and activate NK cells by co-conjugation of anti-CD16 antibodies. This work is a prime example of careful engineering of innovative biomaterials to improve immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical BioSciences, Radboudumc, Geert Grooteplein 26, Nijmegen, GA 6525, the Netherlands; Institute for Chemical Immunology, Nijmegen, GA 6525, the Netherlands; Division of Immunotherapy, Oncode Institute…
- Department of Medical BioSciences, Radboudumc, Geert Grooteplein 26, Nijmegen, GA 6525, the Netherlands; Division of Immunotherapy, Oncode Institute, Radboud University Medical Center, Nijmegen, GA 6525, Netherlands.
- Department of Medical BioSciences, Radboudumc, Geert Grooteplein 26, Nijmegen, GA 6525, the Netherlands.
- Laboratory of Hematology, Department of Laboratory Medicine, Radboudumc, Geert Grooteplein Zuid 10, Nijmegen, GA 6525, USA.
- Joint Department of Biomedical Engineering, University of North Carolina-Chapel Hill & North Carolina State University, Raleigh, NC, USA.
- Department of Medicine Huddinge, Center for Infectious Medicine, Karolinska Institutet, Stockholm, Sweden; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway; The Prec…
Förderung
- NCI NIH HHS
Zitieren
APA
Weiss, L., Schluck, M., Classens, R., de Jonge, P. K. J. D., van der Waart, A., Nguyen, K. G., Nguyen, T. T., Zaharoff, D. A., Malmberg, K. J., Dolstra, H., Figdor, C. G., Sohlberg, E., & Hammink, R. (2025). Interleukin-12 decorated nanosized semiflexible Immunofilaments enable directed targeting and augmented IFNγ responses of natural killer cells. Acta Biomaterialia. https://doi.org/10.1016/j.actbio.2024.11.012
Vancouver
Weiss L, Schluck M, Classens R, de Jonge PKJD, van der Waart A, Nguyen KG, et al. Interleukin-12 decorated nanosized semiflexible Immunofilaments enable directed targeting and augmented IFNγ responses of natural killer cells. Acta Biomaterialia. 2025. doi:10.1016/j.actbio.2024.11.012
BibTeX
@article{Weiss2025,
author = {Weiss, Lea and Schluck, Marjolein and Classens, René and de Jonge, Paul K J D and van der Waart, Anniek and Nguyen, Khue G and Nguyen, Tam T and Zaharoff, David A and Malmberg, Karl-Johan and Dolstra, Harry and Figdor, Carl G and Sohlberg, Ebba and Hammink, Roel},
title = {Interleukin-12 decorated nanosized semiflexible Immunofilaments enable directed targeting and augmented IFNγ responses of natural killer cells},
journal = {Acta Biomaterialia},
year = {2025},
doi = {10.1016/j.actbio.2024.11.012}
}
EUVIMED